YOU ARE DOWNLOADING DOCUMENT

Please tick the box to continue:

Transcript
  • 0.1

    0.15

    0.2

    0.25

    0.3

    0 3 6 9 12 15 18 21 24 27 30 33 36 39 42 45 48 51 54 57 60 63 66 69 72 75 78 81 84 87 90

    Absorbance@

    590nm

    Time(mins)

    Glutamate

    Malate

    Isocitrate

    Lactate

    Co-culture PDAC tumor cells + CAFs respond to combination therapy of APX inhibition and metabolic inhibitor, CPI-613 (25 µM)

    Arrows indicate treatment times.

    0.00

    0.20

    0.40

    0.60

    0.80

    1.00

    1.20

    1.40

    1.60

    1.80

    4 8 12 14

    Tumor Intensity Pa03C+CAF (n=3)

    Ctrl CPI-613 APX3330 Combo

    Days post plating

    Fold

    cha

    nge

    com

    pare

    d to

    unt

    reat

    ed c

    ontro

    l

    0.00

    0.20

    0.40

    0.60

    0.80

    1.00

    1.20

    1.40

    1.60

    1.80

    4 8 12 14

    Tumor Intensity Pa03C+CAF (n=3)

    Ctrl CPI-613 APX2009 Combo

    APX3330=35 µM

    Days post plating

    APX2009=5 µM

    -0.20

    0.00

    0.20

    0.40

    0.60

    0.80

    1.00

    1.20

    1.40

    1.60

    1.80

    4 8 12 14

    Tumor Intensity Pa03C+CAF (n=3)

    Ctrl CPI-613 APX2014 Combo

    Days post plating

    APX2014=2.5 µM

    Ctrl CPI-613 APX Combo

    Co-culture PDAC tumor cells + CAFs respond to combination therapy of APX inhibition and metabolic inhibitor, CPI-613 (25 µM)

    Arrows indicate treatment times.

    0.00

    0.20

    0.40

    0.60

    0.80

    1.00

    1.20

    1.40

    1.60

    1.80

    4 8 12 14

    Tumor Intensity Pa03C+CAF (n=3)

    Ctrl CPI-613 APX3330 Combo

    Days post plating

    Fold

    cha

    nge

    com

    pare

    d to

    unt

    reat

    ed c

    ontro

    l

    0.00

    0.20

    0.40

    0.60

    0.80

    1.00

    1.20

    1.40

    1.60

    1.80

    4 8 12 14

    Tumor Intensity Pa03C+CAF (n=3)

    Ctrl CPI-613 APX2009 Combo

    APX3330=35 µM

    Days post plating

    APX2009=5 µM

    -0.20

    0.00

    0.20

    0.40

    0.60

    0.80

    1.00

    1.20

    1.40

    1.60

    1.80

    4 8 12 14

    Tumor Intensity Pa03C+CAF (n=3)

    Ctrl CPI-613 APX2014 Combo

    Days post plating

    APX2014=2.5 µM

    Ctrl CPI-613 APX Combo

    0

    0.2

    0.4

    0.6

    0.8

    1

    1.2

    Day4 Day8 Day12

    FoldCha

    ngecompa

    redtoSCR

    G SCRG

    SCRLowGSiGSiLowG

    ScRNA-seq data of APE1 knockdown in normoxia and hypoxia

    ScRNA-seq Differential Gene Expression Analysis

    APEX1 Expression

    Normoxia Hypoxia SCR SCR siAPE1 siAPE1

    Fig 5: Validation of scRNA-seq in hypoxia. Expression of various Mitochondrial genes in normoxia and hypoxia, genes assessed via qRT-PCR in Pa03C cells. 3 independent experiments, showing average fold change +/- SD. *p


Related Documents